<DOC>
	<DOCNO>NCT00502554</DOCNO>
	<brief_summary>Investigation photopheresis new therapy regimen patient bronchiolitis obliterans syndrome lung transplantation control , randomize study</brief_summary>
	<brief_title>Extracorporeal Photopheresis Patients With Bronchiolitis Obliterans Syndrome ( BOS ) After Lung Transplantation</brief_title>
	<detailed_description>Bronchiolitis obliterans syndrome major cause mortality lung transplantation . 5 year lung transplantation 50 % patient syndrome . There nearly none therapy option . Besides effective therapy gastrooesophageal reflux oral medication azithromycin none regimen know . Photopheresis could show several study benefit patient gvhd bone marrow transplantation chronic rejection solid organ transplantation . Just little case report could show beneficial effect patient bos lung transplantation . This first control , randomize study patient bos lung transplantation investigate effectiveness therapy patient .</detailed_description>
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Bronchiolitis Obliterans</mesh_term>
	<criteria>Single/Double lung transplantation least 6 month lung transplantation bronchiolitis obliterans syndrome , Stadium &gt; 1 ( nach ISHLT 2001 , FEV1 &lt; 80 % Best ) , none reason worsen lung function ( eg acute rejection , infection , extrapulmonary reason , airway obstruction ) none gastroesophageal reflux medication &gt; 3 month Azithromycin decrease FEV1 , MEF 2575 bioptic prove acute rejection improvement steroid pulse therapy tumor hematologic disease acute rejection respiratory insufficiency ( O2 &gt; 2l/min , pCO2 &gt; 50 mm Hg ) weight &lt; 40 kg acute infection colonization multiresistant pathogen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>lung function</keyword>
	<keyword>FEV1</keyword>
</DOC>